Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Zerbe Insider Profile
4 Followers
Robert Zerbe, Director at Vericel, holds 31.80K shares in Vericel (Ticker: VCEL), holds 202.07K shares in Heron Therapeutics (Ticker: HRTX), holds 0.00 shares in Optimer Pharma (Ticker: OPTR).
Robert Zerbe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Robert Zerbe
Robert Zerbe's Trading History
Vericel
Nov 24, 2020
Director
Uninformative Sell
412.13K
$801.23K
Heron Therapeutics
May 26, 2010
Director
Uninformative Buy
―
$3.64M
Optimer Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Robert Zerbe's performance on stock
You May Also Like
Robert Zerbe insider profile FAQ
What is the percentage of profitable transactions made by Robert Zerbe?
The percentage of profitable transactions made by Robert Zerbe is ―.
What is the average return per transaction made by Robert Zerbe?
The average return per transaction made by Robert Zerbe is ―.
What stocks does Robert Zerbe hold?
Robert Zerbe holds: VCEL, HRTX, OPTR stocks.
What was Robert Zerbe’s latest transaction?
Robert Zerbe latest transaction was an Uninformative Sell of $412.13K.
What was Robert Zerbe's most profitable transaction?
Robert Zerbe’s most profitable transaction was an Informative Buy of VCEL stock on January 24, 2019. The return on the trade was -2.80%.
What is Robert Zerbe's role in Vericel?
Robert Zerbe's role in Vericel is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.